Fact CheckerSign in

NCT07105371CompletedPhase 1

Patients With ALS and Other Motor Disorders Will be Treated With Umbilical or Placental Mesenchymal Cell Exosome Solution

Patients With ALS and Other Motor Discorders Will be Treated With Mesenchymal Cell Exosome Solution

Source: ClinicalTrials.gov · Last updated 16 Oct 2026

Brief summary (registry, in English)

Patients with ALS and other Motor Discorders will be treated with mesenchymal cell exosome solution.

Status (registry)
Completed
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
70 (actual)
First submitted
22 Jul 2025
Start date
14 Jul 2024
Primary completion date
1 May 2026
Lead sponsor
The Foundation for Orthopaedics and Regenerative Medicine
NCT number
NCT07105371

What you commit to

  • Study type: Interventional · Phase 1
  • Participants enrolled: 70
  • From 14 Jul 2024 to the primary completion date, 1 May 2026
  • 2 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients were excluded from the trial if they were pregnant or had active cancer at the screening consultation.

Who the study is looking for

  • Patients will need a diagnosis established by a neurologist. Patients must be able to provide informed consent, or have a guardian who does. They must be able to travel to the site of treatment.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Prodromos Stem Cell Institute
Coordinator of this site? Confirm its status
AthensGreeceUnknown status
Prodromos Stem Cell Institute
Coordinator of this site? Confirm its status
NaplesUnited StatesUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.